HerpeSelect® Express Rapid Test Study Protocol: Sexually Active Adult Population

Completed

Conditions studied: Herpes Simplex Virus 2

In brief

This study is designed to compare the performance of the Focus Diagnostics' HerpeSelect® Express, a Herpes Simplex Virus 2 Rapid Test, to a currently marketed device. The intent is to show the rapid test device is comparable to the currently marketed device. HerpeSelect® Express is a rapid test intended for qualitatively detecting the presence or absence of human IgG class antibodies to herpes simplex virus type 2 (HSV-2) in human whole blood (capillary).

Key facts

Study ID

NCT00655434

Run by

Focus Diagnostics, Inc.

People needed

400

Starts

2008-03-01

Expected to finish

2008-05-01

Last updated by the study team

2009-01-09

Who can join

Age: 18 and older. Sex: any. Healthy volunteers: accepted.

You may qualify if…

• Sexually Active Adults - Intercourse in the last twelve months with at least one sexual partner.
• Subjects must be ≥ 18 years old.
• No more than 60% of one gender.

You may not qualify if…

• <18 years old

Where it is running

• Providence Clinical Research — Burbank, California, United States

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.